Transcription Factor Ets1, but Not the Closely Related Factor Ets2, Inhibits Antibody-Secreting Cell Differentiation

REFERENCES

• Nutt SL, Fairfax KA, Kallies A. 2007. BLIMP1 guides the fate of effector B and T cells. Nat. Rev. Immunol. 7:923–927. http://dx.doi.org/10.1038/nri2204.
   PubMed Web of Science ®Google Scholar
• John SA, Garrett-Sinha LA. 2009. Blimp1: a conserved transcriptional repressor critical for differentiation of many tissues. Exp. Cell Res. 315:1077–1084. http://dx.doi.org/10.1016/j.yexcr.2008.11.015.
   PubMed Web of Science ®Google Scholar
• Iwakoshi NN, Lee AH, Glimcher LH. 2003. The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response. Immunol. Rev. 194:29–38. http://dx.doi.org/10.1034/j.1600-065X.2003.00057.x.
   PubMed Web of Science ®Google Scholar
• Lu R. 2008. Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol. 29:487–492. http://dx.doi.org/10.1016/j.it.2008.07.006.
   PubMed Web of Science ®Google Scholar
• Lin L, Gerth AJ, Peng SL. 2004. Active inhibition of plasma cell development in resting B cells by microphthalmia-associated transcription factor. J. Exp. Med. 200:115–122. http://dx.doi.org/10.1084/jem.20040612.
   PubMedGoogle Scholar
• Cobaleda C, Schebesta A, Delogu A, Busslinger M. 2007. Pax5: the guardian of B cell identity and function. Nat. Immunol. 8:463–470. http://dx.doi.org/10.1038/ni1454.
   PubMed Web of Science ®Google Scholar
• Igarashi K, Ochiai K, Muto A. 2007. Architecture and dynamics of the transcription factor network that regulates B-to-plasma cell differentiation. J. Biochem. 141:783–789. http://dx.doi.org/10.1093/jb/mvm106.
   PubMedGoogle Scholar
• John SA, Clements JL, Russell LM, Garrett-Sinha LA. 2008. Ets-1 regulates plasma cell differentiation by interfering with the activity of the transcription factor Blimp-1. J. Biol. Chem. 283:951–962. http://dx.doi.org/10.1074/jbc.M705262200.
   PubMed Web of Science ®Google Scholar
• Russell L, Garrett-Sinha LA. 2010. Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine 51:217–226. http://dx.doi.org/10.1016/j.cyto.2010.03.006.
   PubMed Web of Science ®Google Scholar
• Garrett-Sinha LA. 2013. Review of Ets1 structure, function, and roles in immunity. Cell. Mol. Life Sci. 70:3375–3390. http://dx.doi.org/10.1007/s00018-012-1243-7.
   PubMedGoogle Scholar
• Woods DB, Ghysdael J, Owen MJ. 1992. Identification of nucleotide preferences in DNA sequences recognised specifically by c-Ets-1 protein. Nucleic Acids Res. 20:699–704. http://dx.doi.org/10.1093/nar/20.4.699.
   PubMedGoogle Scholar
• Ascione R, Thompson DM, Thomas R, Panayiotakis A, Ramsay R, Tymms M, Seth A. 1992. Influence of nucleotides flanking the -GGAA- core sequence on ETS1 and ETS2 DNA-binding activity and the mechanism of ETS1 autoregulation. Int. J. Oncol. 1:631–637.
   PubMed Web of Science ®Google Scholar
• Wasylyk C, Bradford AP, Gutierrez-Hartmann A, Wasylyk B. 1997. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2. Oncogene 14:899–913. http://dx.doi.org/10.1038/sj.onc.1200914.
   PubMed Web of Science ®Google Scholar
• Foulds CE, Nelson ML, Blaszczak AG, Graves BJ. 2004. Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol. Cell. Biol. 24:10954–10964. http://dx.doi.org/10.1128/MCB.24.24.10954-10964.2004.
   PubMed Web of Science ®Google Scholar
• Bhattacharya D, Cheah MT, Franco CB, Hosen N, Pin CL, Sha WC, Weissman IL. 2007. Transcriptional profiling of antigen-dependent murine B cell differentiation and memory formation. J. Immunol. 179:6808–6819. http://www.jimmunol.org/content/179/10/6808.long.
   PubMed Web of Science ®Google Scholar
• Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS, Seth A. 1993. The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc. Natl. Acad. Sci. U. S. A. 90:7588–7592. http://dx.doi.org/10.1073/pnas.90.16.7588.
   PubMed Web of Science ®Google Scholar
• Naviaux RK, Costanzi E, Haas M, Verma IM. 1996. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70:5701–5705.
   PubMed Web of Science ®Google Scholar
• Muthusamy N, Barton K, Leiden JM. 1995. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 377:639–642. http://dx.doi.org/10.1038/377639a0.
   PubMed Web of Science ®Google Scholar
• Wang D, John SA, Clements JL, Percy DH, Barton KP, Garrett-Sinha LA. 2005. Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int. Immunol. 17:1179–1191. http://dx.doi.org/10.1093/intimm/dxh295.
   PubMed Web of Science ®Google Scholar
• Wen F, Tynan JA, Cecena G, Williams R, Munera J, Mavrothalassitis G, Oshima RG. 2007. Ets2 is required for trophoblast stem cell self-renewal. Dev. Biol. 312:284–299. http://dx.doi.org/10.1016/j.ydbio.2007.09.024.
   PubMedGoogle Scholar
• Carotta S, Nutt SL. 2008. Losing B cell identity. Bioessays 30:203–207. http://dx.doi.org/10.1002/bies.20725.
   PubMedGoogle Scholar
• Hollenhorst PC, Jones DA, Graves BJ. 2004. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res. 32:5693–5702. http://dx.doi.org/10.1093/nar/gkh906.
   PubMed Web of Science ®Google Scholar
• Barton K, Muthusamy N, Fischer C, Ting CN, Walunas TL, Lanier LL, Leiden JM. 1998. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9:555–563. http://dx.doi.org/10.1016/S1074-7613(00)80638-X.
   PubMed Web of Science ®Google Scholar
• Bories JC, Willerford DM, Grevin D, Davidson L, Camus A, Martin P, Stehelin D, Alt FW. 1995. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 377:635–638. http://dx.doi.org/10.1038/377635a0.
   PubMed Web of Science ®Google Scholar
• Mouly E, Chemin K, Nguyen HV, Chopin M, Mesnard L, Leite-de-Moraes M, Burlen-Defranoux O, Bandeira A, Bories JC. 2010. The Ets-1 transcription factor controls the development and function of natural regulatory T cells. J. Exp. Med. 207:2113–2125. http://dx.doi.org/10.1084/jem.20092153.
   PubMedGoogle Scholar
• Yamamoto H, Flannery ML, Kupriyanov S, Pearce J, McKercher SR, Henkel GW, Maki RA, Werb Z, Oshima RG. 1998. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev. 12:1315–1326. http://dx.doi.org/10.1101/gad.12.9.1315.
   PubMed Web of Science ®Google Scholar
• Werner MH, Clore GM, Fisher CL, Fisher RJ, Trinh L, Shiloach J, Gronenborn AM. 1997. Correction of the NMR structure of the ETS1/DNA complex. J. Biomol. NMR 10:317–328. http://dx.doi.org/10.1023/A:1018399711996.
   PubMed Web of Science ®Google Scholar
• Garvie CW, Hagman J, Wolberger C. 2001. Structural studies of Ets-1/Pax5 complex formation on DNA. Mol. Cell 8:1267–1276. http://dx.doi.org/10.1016/S1097-2765(01)00410-5.
   PubMed Web of Science ®Google Scholar
• Obika S, Reddy SY, Bruice TC. 2003. Sequence specific DNA binding of Ets-1 transcription factor: molecular dynamics study on the Ets domain-DNA complexes. J. Mol. Biol. 331:345–359. http://dx.doi.org/10.1016/S0022-2836(03)00726-5.
   PubMedGoogle Scholar
• Seidel JJ, Graves BJ. 2002. An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. Genes Dev. 16:127–137. http://dx.doi.org/10.1101/gad.950902.
   PubMed Web of Science ®Google Scholar
• Yang BS, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ, Hume DA, Maki RA, Ostrowski MC. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538–547.
   PubMed Web of Science ®Google Scholar
• Nelson ML, Kang HS, Lee GM, Blaszczak AG, Lau DK, McIntosh LP, Graves BJ. 2010. Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP. Proc. Natl. Acad. Sci. U. S. A. 107:10026–10031. http://dx.doi.org/10.1073/pnas.0915137107.
   PubMed Web of Science ®Google Scholar
• Ji Z, Degerny C, Vintonenko N, Deheuninck J, Foveau B, Leroy C, Coll J, Tulasne D, Baert JL, Fafeur V. 2007. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation. Oncogene 26:395–406. http://dx.doi.org/10.1038/sj.onc.1209789.
   PubMed Web of Science ®Google Scholar
• Macauley MS, Errington WJ, Scharpf M, Mackereth CD, Blaszczak AG, Graves BJ, McIntosh LP. 2006. Beads-on-a-string, characterization of ETS-1 sumoylated within its flexible N-terminal sequence. J. Biol. Chem. 281:4164–4172. http://dx.doi.org/10.1074/jbc.M510488200.
   PubMedGoogle Scholar
• Nishida T, Terashima M, Fukami K. 2006. PIASy-mediated repression of the Ets-1 is independent of its sumoylation. Biochem. Biophys. Res. Commun. 345:1536–1546. http://dx.doi.org/10.1016/j.bbrc.2006.05.065.
   PubMed Web of Science ®Google Scholar
• Hollenhorst PC, Shah AA, Hopkins C, Graves BJ. 2007. Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev. 21:1882–1894. http://dx.doi.org/10.1101/gad.1561707.
   PubMed Web of Science ®Google Scholar
• Gallant S, Gilkeson G. 2006. ETS transcription factors and regulation of immunity. Arch. Immunol. Ther. Exp. (Warsz.) 54:149–163. http://dx.doi.org/10.1007/s00005-006-0017-z.
   PubMed Web of Science ®Google Scholar
• Hollenhorst PC, McIntosh LP, Graves BJ. 2011. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu. Rev. Biochem. 80:437–471. http://dx.doi.org/10.1146/annurev.biochem.79.081507.103945.
   PubMed Web of Science ®Google Scholar
• Garrett-Sinha LA, Dahl R, Rao S, Barton KP, Simon MC. 2001. PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1. Blood 97:2908–2912. http://dx.doi.org/10.1182/blood.V97.9.2908.
   PubMedGoogle Scholar
• Garrett-Sinha LA, Su GH, Rao S, Kabak S, Hao Z, Clark MR, Simon MC. 1999. PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity 10:399–408. http://dx.doi.org/10.1016/S1074-7613(00)80040-0.
   PubMedGoogle Scholar
• Wei G, Srinivasan R, Cantemir-Stone CZ, Sharma SM, Santhanam R, Weinstein M, Muthusamy N, Man AK, Oshima RG, Leone G, Ostrowski MC. 2009. Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood 114:1123–1130. http://dx.doi.org/10.1182/blood-2009-03-211391.
   PubMedGoogle Scholar
• Maroulakou IG, Papas TS, Green JE. 1994. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene 9:1551–1565.
   PubMed Web of Science ®Google Scholar
• Kallies A, Hasbold J, Fairfax K, Pridans C, Emslie D, McKenzie BS, Lew AM, Corcoran LM, Hodgkin PD, Tarlinton DM, Nutt SL. 2007. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1. Immunity 26:555–566. http://dx.doi.org/10.1016/j.immuni.2007.04.007.
   PubMed Web of Science ®Google Scholar
• Lin KI, Angelin-Duclos C, Kuo TC, Calame K. 2002. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol. Cell. Biol. 22:4771–4780. http://dx.doi.org/10.1128/MCB.22.13.4771-4780.2002.
   PubMedGoogle Scholar
• Slupsky CM, Gentile LN, Donaldson LW, Mackereth CD, Seidel JJ, Graves BJ, McIntosh LP. 1998. Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site. Proc. Natl. Acad. Sci. U. S. A. 95:12129–12134. http://dx.doi.org/10.1073/pnas.95.21.12129.
   PubMed Web of Science ®Google Scholar
• Schmidlin H, Diehl SA, Nagasawa M, Scheeren FA, Schotte R, Uittenbogaart CH, Spits H, Blom B. 2008. Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression. Blood 112:1804–1812. http://dx.doi.org/10.1182/blood-2008-01-136440.
   PubMedGoogle Scholar